Association between Osteocalcin, Metabolic Syndrome, and Cardiovascular Risk Factors: Role of Total and Undercarboxylated Osteocalcin in Patients with Type 2 Diabetes
Figure 1
Serum total and undercarboxylated osteocalcin levels in relation to the number of metabolic syndrome components. Data are expressed as mean ± SEM. A significant decrease in total osteocalcin levels was observed with a higher number of metabolic syndrome components (). A Similar trend was observed with the undercarboxylated osteocalcin but this did not reach statistical significance ().
